Studies have consistently shown elevated TIM-3 expression on CD8+ T cells isolated from HBV-infected patients across various clinical phases, including CHB, AHB, LC, and HCC, compared to healthy controls (145, 149). The gene discussed is HAVCR2; the disease is hepatocellular carcinoma.